We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » IRB, Investigator Duties Clarified In Final Trial Reviews Guidance
IRB, Investigator Duties Clarified In Final Trial Reviews Guidance
February 29, 2012
While IRBs must conduct at least one review each year for ongoing trials, more frequent reviews may be appropriate for trials with greater risk, such as those with a vulnerable population or an investigator with a poor compliance history, an FDA final guidance states.